WÄDENSWIL, Switzerland—Countering prior theories soy isoflavone supplementation can contribute to increased breast cancer risk, new findings from the Osteoporosis Prevention Using Soy (OPUS) intervention study, funded by the USDA, has confirmed that long-term supplementation with soy hypocotyl isoflavones does not cause adverse effects. The findings wee published in the American Journal of Clinical Nutrition (2011; [...]
Tag Archives | OTC supplements
Recent Posts
- Safety aspects of soyfoods and soy isoflavones in men
- Safety of Frutarom`s daidzein rich SoyLife products
- SoyLife Overview
- Soylife, Calcium and Vit D in the prevention of osteoporosis – OPUS study 2004–2007
- SoyLife® Extra
- Soy isoflavone supplementation enhances spatial working memory in Men
- Safety evaluation of SoyLife
- Various doses of soy isoflavones do not modify mammographic density in postmenopausal women
- Soy isoflavone supplementation elevates erythrocyte superoxide dismutase, but not plasma ceruloplasmin in postmenopausal breast cancer survivors
- Estrogenic activity of glycitein, a soy isoflavone

